Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.

Jonasson, J M; Ljung, R; Talbäck, M; Haglund, B; Gudbjörnsdòttir, S; Steineck, G
Diabetologia; 2009 Sep;52(9):1745-54. PMID: 19588120
Division of Clinical Cancer Epidemiology, Department of Oncology, Onkologiskt Centrum, Sahlgrenska Academy, 41345, Gothenburg, Sweden.


In the light of a report suggesting that insulin glargine may increase cancer occurrence, the EASD asked us to perform this study.